scispace - formally typeset
A

Andrew C. Edmondson

Researcher at Children's Hospital of Philadelphia

Publications -  62
Citations -  5910

Andrew C. Edmondson is an academic researcher from Children's Hospital of Philadelphia. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 21, co-authored 46 publications receiving 5220 citations. Previous affiliations of Andrew C. Edmondson include University of Pennsylvania & Brigham Young University.

Papers
More filters
Journal ArticleDOI

Biological, clinical and population relevance of 95 loci for blood lipids

Tanya M. Teslovich, +218 more
- 05 Aug 2010 - 
TL;DR: The results identify several novel loci associated with plasma lipids that are also associated with CAD and provide the foundation to develop a broader biological understanding of lipoprotein metabolism and to identify new therapeutic opportunities for the prevention of CAD.
Journal ArticleDOI

Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

Zari Dastani, +618 more
- 29 Mar 2012 - 
TL;DR: A meta-analysis of genome-wide association studies in 39,883 individuals of European ancestry to identify genes associated with metabolic disease identifies novel genetic determinants of adiponectin levels, which, taken together, influence risk of T2D and markers of insulin resistance.
Journal ArticleDOI

Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies

Brendan J. Keating, +66 more
- 31 Oct 2008 - 
TL;DR: A gene-centric 50 K single nucleotide polymorphism (SNP) array to assess potentially relevant loci across a range of cardiovascular, metabolic and inflammatory syndromes and it is demonstrated that the IBC array can be used to complement GWAS, increasing coverage in high priority CVD-related lociAcross all major HapMap populations.
Journal ArticleDOI

Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism

TL;DR: Functional evidence is provided that genetically increased hepatic sortilin expression both reduces hepatic apolipoprotein B secretion and increases LDL catabolism, providing dual mechanisms for the very strong association between increased hepatics sortil in expression and reduced plasma LDL-C levels in humans.